Migaldendranib

Migaldendranib · Ashvattha Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Migaldendranib, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers [Phase 1]